ACTUATE THERAPEUTICS, INC. ACTU
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-08-13
ACTUATE THERAPEUTICS, INC. statistics & valuation
Market cap$40.2M
P / B5.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -158.4% | -292.8% | -826.0% |
| Return on equity | -280.5% | -26189.1% | 24.8% |
| Current ratio | 2.39 | 1.05 | 0.43 |
Source: SEC EDGAR filings · CIK 0001652935 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.